| Date |
Title |
Rating |
| 2010-10-31 |
FDA new approvals, antibiotic and neurological drugs |
None |
| 2010-10-30 |
Health Canada approves PRADAX for preventing stroke in AF patients |
5 |
| 2010-10-30 |
Rite Aid to host flu shot clinics at nationwide pharmacies |
None |
| 2010-10-30 |
EcoNugenics introduces new nutraceutical compound for breast health |
None |
| 2010-10-30 |
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia |
None |
| 2010-10-30 |
Inter Press Service reports on counterfeit medicine challenges in central, Eastern Europe |
None |
| 2010-10-30 |
APP receives FDA marketing approval for Metoprolol Tartrate Injection |
None |
| 2010-10-30 |
FDA approves NUEDEXTA capsules for pseudobulbar affect |
None |
| 2010-10-30 |
Teflaro receives FDA approval for treatment of bacterial infections |
None |
| 2010-10-30 |
Drug and device makers face new taxes, fees |
None |
| 2010-10-29 |
Pneumonia vaccination increases among older Americans, but still falls short of Healthy People 2010 goal |
None |
| 2010-10-29 |
SPRYCEL receives FDA approval for treating adult patients with Ph+ CML in chronic phase |
1 |
| 2010-10-29 |
DiaGenic third quarter income increases from NOK -9.3 million to NOK -9.6 million |
None |
| 2010-10-29 |
ACADIA and BLS enter agreement to conclude pimavanserin collaboration |
None |
| 2010-10-29 |
PHARMABIZ.com examines India’s push for clearer definition of counterfeit, substandard medicines |
None |
| 2010-10-29 |
VIVUS receives FDA CRL for QNEXA NDA |
None |
| 2010-10-29 |
Nursing homes struggle to allow seniors use of medical marijuana |
None |
| 2010-10-29 |
FDA approves Sprycel for treatment of adults with Ph+ CP-CML |
2 |
| 2010-10-29 |
Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain |
4 |
| 2010-10-29 |
Latuda tablets receive FDA approval for treatment of adults with schizophrenia |
3 |
| 2010-10-28 |
Tenofovir gel to prevent HIV transmission nearing approval |
1 |
| 2010-10-28 |
Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia |
None |
| 2010-10-28 |
CCS presents new 2010 Atrial Fibrillation Guidelines |
None |
| 2010-10-28 |
Federal Government seizes prescription and OTC drug products from Tri-Med Labs |
None |
| 2010-10-28 |
Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical |
None |
| 2010-10-28 |
B. Braun initiates voluntary recall of heparin injection products |
None |
| 2010-10-28 |
Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients |
3.2 |
| 2010-10-28 |
Reuters examines development progress of microbicide gel to prevent HIV |
None |
| 2010-10-28 |
Prolonged use of glucosamine linked to greater risk of developing diabetes |
None |
| 2010-10-28 |
Sandoz initiates voluntary recall of Methotrexate Injection |
None |
| 2010-10-28 |
Glaxo to pay $750 million settlement for defective, unsafe medicines |
None |
| 2010-10-27 |
£600 million cancer drug fund for UK cancer patients |
None |
| 2010-10-27 |
US FDA cracks down on importation of unapproved new drugs for personal use |
None |
| 2010-10-27 |
Shionogi receives expanded approval for pediatric use of i.v. peramivir in Japan |
None |
| 2010-10-27 |
BTG selects inVentiv Commercial to provide sales and training for CroFab, DigiFab products |
None |
| 2010-10-27 |
Quebec recognizes value of ABILIFY for treating schizophrenia and related psychotic disorders |
3.8 |
| 2010-10-27 |
B.C. pharmacists are authorized to administer flu shots |
None |
| 2010-10-27 |
New guideline for using ESAs drugs in cancer patients |
None |
| 2010-10-27 |
Bivalent oral polio vaccine produces better immune response than more commonly used trivalent vaccine, study says |
None |
| 2010-10-27 |
Study finds association between KRAS p.G13D mutations and cetuximab treatment in colorectal cancer |
None |
| 2010-10-27 |
Study finds anti-obesity drug reduces brain’s response to appetizing foods |
None |
| 2010-10-27 |
Jamieson releases flu-fighting formula with echinacea |
3 |
| 2010-10-27 |
CYP2C19 gene variant can increase risk of cardiovascular events in patients treated with clopidogrel |
None |
| 2010-10-26 |
Glaxo to pay $750 million in defective drug settlement |
None |
| 2010-10-26 |
Strativa enters amended agreement with Sobi for Nascobal Vitamin B12 Nasal Spray |
None |
| 2010-10-26 |
Shire receives Paragraph IV Notice Letter from Watson for INTUNIV tablet |
None |
| 2010-10-26 |
India's Trade Minister says EU will take steps to prevent seizure of generic medicines |
None |
| 2010-10-26 |
PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics |
None |
| 2010-10-26 |
PAREXEL's white paper provides data on biopharmaceutical, medical device product development |
None |
| 2010-10-26 |
Independent drugstores expand and generate strong profits despite worst economy |
None |
| 2010-10-26 |
Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent |
None |
| 2010-10-26 |
Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older |
None |
| 2010-10-26 |
Omeros to develop new drugs for major diseases |
None |
| 2010-10-26 |
Pharmacopeias of US and Kazakhstan sign accord |
None |
| 2010-10-26 |
Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey |
None |
| 2010-10-26 |
IDC grants MedImmune global rights to GLA adjuvant |
None |
| 2010-10-26 |
DERMAGENICS Collagen Recovery Cream helps revitalize skin damaged by radiation, chemotherapy |
None |
| 2010-10-26 |
Savient to evaluate strategic alternatives for KRYSTEXXA drug |
None |
| 2010-10-26 |
AAHP highlights safety of homeopathic children's medicines |
None |
| 2010-10-26 |
PhRMA representatives meet with officials in India to discuss compulsory licensing |
None |
| 2010-10-26 |
Aspirin reduces risk of death from prostate cancer |
None |
| 2010-10-26 |
Dietary intake of PUFAs associated with decreased prevalence of periodontitis |
None |
| 2010-10-26 |
Baxter announces launch of GLASSIA in the U.S. |
None |
| 2010-10-26 |
CBER's Laboratory Quality System program receives accreditation |
None |
| 2010-10-25 |
S.A.N.E. Vax requests temporary suspension of Gardasil sales as cervical cancer preventive |
None |
| 2010-10-25 |
Immune Network enters letter of intent to acquire Immunitor oral vaccine technology |
None |
| 2010-10-25 |
Neptune launches Onemia medical food |
None |
| 2010-10-25 |
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides |
None |
| 2010-10-25 |
FDA warns about risk of Hyland's Teething Tablets to children |
None |
| 2010-10-25 |
Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine |
None |
| 2010-10-25 |
Research finds succimer drug not effective in removing mercury |
None |
| 2010-10-25 |
Vancomycin beneficial for managing patients hospitalized with cellulits |
None |
| 2010-10-25 |
Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine |
None |
| 2010-10-25 |
FDA issues complete response letter for ViroPharma's Cinryze |
None |
| 2010-10-25 |
Arena's NDA receives Complete Response Letter for lorcaserin |
None |
| 2010-10-25 |
FDA approves LO LOESTRIN FE tablets for oral contraception |
None |
| 2010-10-25 |
FDA approves REMS for NUVIGIL and PROVIGIL tablets |
5 |
| 2010-10-22 |
Quest Diagnostics reports use of prescription opiates by American workers has increased by 40% |
5 |
| 2010-10-22 |
New multi-centre trial to treat cold and flu in children |
None |
| 2010-10-22 |
Medivir reports consolidated net sales of SEK 54.7M |
None |
| 2010-10-22 |
Diamyd Medical to divide operations into two business areas |
2 |
| 2010-10-22 |
Researchers analyze drugs' efficiency on influenza A virus |
5 |
| 2010-10-22 |
Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts |
None |
| 2010-10-22 |
Six government drug control laboratories in MENA to join USP to improve quality of drugs |
None |
| 2010-10-22 |
Cephalon signs convertible note subscription agreement with ChemGenex Pharmaceuticals |
None |
| 2010-10-22 |
FDA announces new label for HIV antiviral drug Invirase |
None |
| 2010-10-22 |
Hospira announces launch of piperacillin and tazobactam injection in the US |
None |
| 2010-10-22 |
Drug payment database spurs local reports |
None |
| 2010-10-22 |
Research suggests lowering cholesterol can reduce benign prostatic hyperplasia |
4 |
| 2010-10-22 |
Medtronic's Xpander II receives FDA clearance for vertebral compression fractures |
None |
| 2010-10-22 |
Neoprobe submits BLA response letter to FDA to commercialize RIGS technology |
None |
| 2010-10-22 |
Biogen, Genentech announce new structure of anti-CD20 collaboration |
None |
| 2010-10-22 |
Daiichi Sankyo launches Inavir inhalation powder in Japan |
None |
| 2010-10-21 |
Health Canada approves ULORIC to lower serum uric acid levels in patients with gout |
None |
| 2010-10-21 |
Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets |
None |
| 2010-10-21 |
Genmab A/S reports DKK 78 million in net sales for Arzerra |
None |
| 2010-10-21 |
New PharmaDeals v4 online resource to support pharmaceutical industry |
None |
| 2010-10-21 |
Nonprescription drug manufacturing and marketing costs increase: Kline |
None |
| 2010-10-21 |
FDA asks manufacturers to add new warnings to labeling of prostate cancer drugs |
None |
| 2010-10-21 |
PMAI offers new addiction treatment options for opioid dependence |
None |
| 2010-10-21 |
Valensa enters agreement with Mercola for Flex Pro ES formulation |
None |
| 2010-10-21 |
FDA issues complete response letter for BYDUREON NDA |
None |
| 2010-10-21 |
FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer |
None |
| 2010-10-20 |
Cipla launches generic Pirfenidone for IPF |
4 |
| 2010-10-20 |
BREAKYL drug receives European approval |
None |
| 2010-10-20 |
Pfizer enters partnership with Teuto to develop, commercialize generic medicines |
None |
| 2010-10-20 |
CRN reinforces importance of DHA before, during and after pregnancy |
None |
| 2010-10-20 |
PBS-Bio announces three new contracts to develop cancer therapy |
None |
| 2010-10-20 |
More studies needed on bisphosphonates therapy and fracture risk |
None |
| 2010-10-20 |
Pharsight launches Phoenix Pharmacometric Productivity Challenge |
None |
| 2010-10-20 |
FDA approves Boehringer Ingelheim's Pradaxa for stroke risk reduction in patients with non-valvular AF |
5 |
| 2010-10-20 |
Nitric oxide inhalation reduces pain in sickle cell disease patients |
None |
| 2010-10-20 |
Aspirin before cardiac surgery reduces postoperative cardiocerebral complications |
None |
| 2010-10-20 |
Study finds ketamine-propofol combination effective for pediatric procedural sedation |
5 |
| 2010-10-20 |
Particle Sciences enters licensing, technology agreement with Solubest |
None |
| 2010-10-20 |
Salix acquires rights to colon cancer screening agent from Photocure |
None |
| 2010-10-20 |
Osteoporosis drug heals bone wounds in gum disease patients |
5 |
| 2010-10-20 |
Dexamethasone improves quality of life after laparoscopic gallbladder surgery |
4 |
| 2010-10-20 |
AMP's automated IMA tube filling line receives commercial approval |
None |
| 2010-10-20 |
Pradaxa capsules receive FDA approval for reducing stroke and systemic embolism risk in AFib patients |
2.5 |
| 2010-10-20 |
Adamis acquires prostrate drug candidates from Colby Pharmaceuticals |
None |
| 2010-10-20 |
European Commission grants orphan drug status to OBI-1 for hemophilia treatment |
None |
| 2010-10-20 |
En Ze Jia Shi Pharmaceuticals receives patent for controlled-release oral gliclazide |
None |
| 2010-10-20 |
Alexza reacquires U.S. and Canadian rights for Staccato Loxapine from BLS |
None |
| 2010-10-20 |
Anticoagulant Pradaxa receives FDA approval for prevention of stroke in atrial fibrillation patients |
3.5 |
| 2010-10-19 |
Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million |
None |
| 2010-10-19 |
Flamel announces achievement of clinical development milestone with Merck Serono |
None |
| 2010-10-19 |
Research calls for better environmental risk assessments of pharmaceuticals |
None |
| 2010-10-19 |
Arcadia Biosciences receives Canadian marketing clearance for SONOVA 400 health product |
None |
| 2010-10-19 |
Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion |
None |
| 2010-10-19 |
Few legitimate opioid users are getting information to keep medications safe |
4 |
| 2010-10-19 |
Annals of Internal Medicine raises concerns over placebo standard |
None |
| 2010-10-19 |
60 Plus applauds FDA decision to remove unapproved colchicine products |
1 |
| 2010-10-19 |
Long-term use of statins reduces colorectal cancer risk |
None |
| 2010-10-19 |
Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases |
None |
| 2010-10-19 |
New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR |
None |
| 2010-10-19 |
EMA Pediatric Committee adopts positive opinion for CTI's Pixuvri for lymphoid malignancies, solid tumors |
None |
| 2010-10-19 |
Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs |
None |
| 2010-10-19 |
NCCN updates Clinical Practice Guidelines for Breast Cancer |
None |
| 2010-10-19 |
Mylan to appeal against court decision in generic Paxil CR case against GlaxoSmithKline and Apotex |
None |
| 2010-10-19 |
NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy |
None |
| 2010-10-19 |
Elorac acquires world-wide rights to Cidoxepin |
None |
| 2010-10-19 |
Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA |
None |
| 2010-10-18 |
Tylenol batch recalled due to strange smell |
None |
| 2010-10-18 |
STB completes Fibrin Adhesive STat pre-IND submission to FDA |
None |
| 2010-10-18 |
FDA approves Teva's generic Prevacid SoluTab ANDA |
None |
| 2010-10-18 |
PharmaTrust to launch third generation MedCentre remote dispensing system |
None |
| 2010-10-18 |
Lannett announces launch of Fluphenazine HCl Tablets |
None |
| 2010-10-18 |
GeoVax Labs contributes article for HIV vaccine |
None |
| 2010-10-18 |
NanoViricides' President delivers speech at ASNM Second Annual Conference |
None |
| 2010-10-18 |
Emollient creams on eczemous skin likely to make condition worse |
None |
| 2010-10-18 |
Biocon, Pfizer enter global agreement to commercialize Insulin analog products |
None |
| 2010-10-18 |
Fera Pharmaceuticals launches Garamycin Ophthalmic Ointment |
None |
| 2010-10-18 |
Bend Research extends 3-year agreement with Bristol-Myers Squibb |
None |
| 2010-10-18 |
Intellipharmaceutics announces FDA acceptance to file ANDA for Protonix generic version |
None |
| 2010-10-18 |
Researchers to develop technologies that can mask horrid taste of children's medicines |
None |
| 2010-10-18 |
Study finds correlation between flu vaccination and Medicaid reimbursement rates |
None |
| 2010-10-18 |
Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine |
None |
| 2010-10-18 |
New discovery raises hopes for women with tamoxifen resistance |
None |
| 2010-10-18 |
Bioniche's research scientists give presentations at Modern Vaccine and Adjuvant Formulation Conference |
3 |
| 2010-10-18 |
IDRI's TB vaccine protects against drug-resistant tuberculosis |
None |
| 2010-10-18 |
CVS agrees to record fine to settle meth suit |
None |
| 2010-10-18 |
Botox receives FDA approval for treatment of chronic migraine |
None |
| 2010-10-18 |
Genmab provides update on potential regulatory pathway for zalutumumab |
None |
| 2010-10-18 |
ACG meeting to exhibit Cimzia data for Crohn's disease treatment |
None |
| 2010-10-18 |
Three West African countries set to roll out new meningitis vaccine |
None |
| 2010-10-18 |
FDA plans to revoke knee implant approval following intense political pressure for its approval |
None |
| 2010-10-18 |
FDA approves ISTA's sNDA for BROMDAY ophthalmic anti-inflammatory drug |
None |
| 2010-10-18 |
FDA approves BOTOX as prophylactic treatment for Chronic Migraine |
None |
| 2010-10-15 |
MasterCard, Interpol partner to prevent online supply of illegal and counterfeit drugs, medicines |
None |
| 2010-10-15 |
Oragenics to feature ProBiora3 oral care probiotic ingredient at Supply Side West |
None |
| 2010-10-15 |
Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval |
None |
| 2010-10-15 |
Access receives first MuGard prescriptions and reimbursement |
None |
| 2010-10-15 |
Watson Laboratories receives FDA approval for Amlodipine capsules |
None |
| 2010-10-15 |
Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML |
1 |
| 2010-10-15 |
CVS Caremark to present client experiences on innovative approaches at AMCP Conference |
None |
| 2010-10-15 |
Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs |
None |
| 2010-10-15 |
FDA warns companies over unsubstantiated claims of 'chelation' products |
None |
| 2010-10-15 |
A new therapeutic approach for cancer |
None |
| 2010-10-15 |
Visa supports global law enforcement action against online sale of counterfeit, illegal medicines |
None |
| 2010-10-15 |
Scientists to monitor effectiveness of Streptococcus vaccine |
None |
| 2010-10-15 |
Startech, STRCIC invest $2.5 million in ViroXis Corporation |
None |
| 2010-10-15 |
GfK HealthCare: RRMS patients anticipate availability of new oral therapies |
None |
| 2010-10-15 |
CVS/pharmacy agrees to pay civil penalties for excessive sales of PSE |
None |
| 2010-10-15 |
Delcath executes melphalan supply agreement with Synerx and Bioniche Teoranta |
5 |
| 2010-10-15 |
Proper dosing of beta blockers can save many lives after heart attack |
None |
| 2010-10-15 |
Officials address several drug issues including medical risks, proper disposal of unused medicine |
None |
| 2010-10-15 |
Administering ondansetron drug to children is economically advantageous |
None |
| 2010-10-15 |
Scientists discover mechanism of anticancer drug to kill cancer cells |
None |
| 2010-10-15 |
FDA approves Cephalon's REMS for GABITRIL |
None |
| 2010-10-15 |
Lantheus announces Canadian launch of ABLAVAR injection |
None |
| 2010-10-15 |
Moores Cancer Center files IND application for topical NexACT-based formulation |
None |
| 2010-10-15 |
FDA approves Gamunex-C for primary immunodeficiency treatment |
None |
| 2010-10-15 |
Acetadote Injection is now commercially available in Australia |
None |
| 2010-10-14 |
NanoViricides files financial year end annual report with SEC |
None |
| 2010-10-14 |
Report on world market for diabetes treatments |
None |
| 2010-10-14 |
Labopharm, Paladin Labs expand commercial relationship |
None |
| 2010-10-14 |
Top biopharma leaders to share strategies at Windhover's 2nd PharmAsia Summit |
None |
| 2010-10-14 |
Marijuana legalization in California will marginally impact revenues of Mexican drug trafficking organizations |
None |
| 2010-10-14 |
Dangers of over the counter 'natural' slimming products |
None |
| 2010-10-14 |
FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates |
None |
| 2010-10-14 |
Study finds hemostatic powder effective in treating 95% of patients with bleeding peptic ulcers |
5 |
| 2010-10-14 |
Risingsun signs consent decree to stop selling unapproved drugs |
None |
| 2010-10-14 |
World's third rectal microbicide trial launched in Pittsburgh |
None |
| 2010-10-14 |
GSK to expand donation of albendazole medicine to treat children with STH risk |
None |
| 2010-10-14 |
Workshop to focus on FDA process that grants orphan drug designation |
None |
| 2010-10-14 |
Justices wrestle with issue of protecting vaccine makers |
None |
| 2010-10-14 |
Labopharm announces European approval of twice-daily tramadol-acetaminophen |
None |
| 2010-10-14 |
Stop TB Partnership launches Global Plan to Stop TB 2011-2015 |
None |
| 2010-10-14 |
Scientists suggest lemon-lime soft drink can improve effectiveness of oral anticancer drug |
None |
| 2010-10-14 |
NIH awards grant to Bavarian to advance early research in filoviruses |
None |
| 2010-10-14 |
Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis |
None |
| 2010-10-13 |
Antidepressant Reboxetine ineffective: Review |
None |
| 2010-10-13 |
AusBiotech 2010 set to demystify the impact of US Healthcare Reforms on Australian biotech |
None |
| 2010-10-13 |
Mesoblast broadens cancer indications for bone marrow transplant product |
5 |
| 2010-10-13 |
ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment |
None |
| 2010-10-13 |
Researchers investigate statin drugs to treat lung disease |
None |
| 2010-10-13 |
Physicians anticipate new oral therapies for multiple sclerosis patients |
None |
| 2010-10-13 |
Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation |
None |
| 2010-10-13 |
Buprenorphine implant decreases opioid usage in persons with opioid dependence |
None |
| 2010-10-13 |
The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence |
None |
| 2010-10-13 |
LifeWise improves access to common immunizations at pharmacies |
None |
| 2010-10-13 |
BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA |
None |
| 2010-10-13 |
CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals |
None |
| 2010-10-13 |
B. Braun Medical announces availability of FDA-approved Cefepime in DUPLEX System |
None |
| 2010-10-13 |
Alkermes' VIVITROL medication for treatment of opioid dependence |
None |
| 2010-10-13 |
High Court to hear vaccine case |
None |
| 2010-10-13 |
Actavis receives FDA marketing approval for generic Cozaar |
None |
| 2010-10-13 |
Auxilium receives USPTO patent for XIAFLEX product |
None |
| 2010-10-13 |
Centice introduces new PINPOINT Rx system for drug identification |
None |
| 2010-10-13 |
More insured Americans avoid prescription drugs due to cost |
None |
| 2010-10-13 |
FDA approves Vivitrol for treatment of opioid-dependent patients |
None |
| 2010-10-12 |
Vaccine lawsuits – Justices divided |
None |
| 2010-10-12 |
Smart for Life(R) to add Lepticore(R) to product line |
None |
| 2010-10-12 |
EMA approves TWYNSTA therapy that reduces BP in hypertensive patients |
2.1 |
| 2010-10-12 |
Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets |
1 |
| 2010-10-12 |
Abbott agrees to voluntarily withdraw obesity drug Meridia from U.S. market |
None |
| 2010-10-12 |
Study finds no link between AMD treatments and increase in cardiovascular complication |
None |
| 2010-10-12 |
Folic acid supplement does not reduce cardiovascular events, cancer or death |
None |
| 2010-10-12 |
Combination therapy for ovarian cancer leads to greater toxicity |
None |
| 2010-10-12 |
Women with epilepsy at risk of infertility |
None |
| 2010-10-11 |
New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer |
None |
| 2010-10-11 |
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer |
None |
| 2010-10-11 |
Sexual issues a major concern for cancer patients taking new targeted drugs |
None |
| 2010-10-11 |
Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds |
None |
| 2010-10-11 |
Attorney Keith Jensen announces $3.78 million settlement with Pfizer on TEN case |
None |
| 2010-10-11 |
Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019 |
None |
| 2010-10-11 |
Genta announces EMA Orphan Drug designation for tesetaxel |
None |
| 2010-10-11 |
FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis |
None |
| 2010-10-11 |
Valeant announces Alexza's receipt of FDA CRL for AZ-004 NDA |
None |
| 2010-10-11 |
FDA issues CRL for AZ-004 NDA application |
None |
| 2010-10-11 |
FDA issues CRL to Jazz for JZP-6 NDA for fibromyalgia |
None |
| 2010-10-11 |
FDA warns of harmful stimulant in Slimming Beauty capsules |
None |
| 2010-10-11 |
HHS awards Sanofi Pasteur 3-year, $56.94M egg supply contract for pandemic vaccine preparedness |
None |
| 2010-10-11 |
Abbott to withdraw sibutramine from Canadian market |
None |
| 2010-10-11 |
Drugs may prevent temporary combativeness in children after surgery |
None |
| 2010-10-11 |
Takeda, Envoy enter three-year research alliance to develop schizophrenia drug |
None |
| 2010-10-11 |
Abbott to withdraw Meridia medicine from the U.S. market |
None |
| 2010-10-11 |
Researchers create experimental vaccine for Alzheimer's disease |
None |
| 2010-10-10 |
Meridia – weight loss pill off the shelves in US |
None |
| 2010-10-10 |
Weight loss pill off shelves due to heart attack risk |
None |
| 2010-10-08 |
Biologists determine three-dimensional structure of molecule involved in HIV, cancer |
None |
| 2010-10-08 |
Suneva Medical publishes Artefill data for treatment of atrophic acne scars |
None |
| 2010-10-08 |
CMA to apply intervener status in Insite case |
None |
| 2010-10-08 |
Industry leaders recognised at Frost & Sullivan's Excellence in Best Practices Awards Banquet |
None |
| 2010-10-08 |
MRSA pathogen influences U.S. physician drug selection for treating skin structure infections |
None |
| 2010-10-08 |
Spanish mothers more concerned about the safety of childhood vaccines |
None |
| 2010-10-08 |
CDC issues new universal influenza vaccination recommendation for all Americans |
None |
| 2010-10-08 |
IV ibuprofen effective in reducing fever in hospitalized patients |
1 |
| 2010-10-08 |
Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news |
None |
| 2010-10-08 |
Endo grants Watson royalty-free license to U.S. patents |
None |
| 2010-10-08 |
Emergent BioSolutions and TLV form new joint venture to develop flu vaccines |
None |
| 2010-10-08 |
U.N. Secretary-General urges funding for GAVI during replenishment meeting |
None |
| 2010-10-08 |
NIAID announces three new contracts to fund research on dengue, anthrax vaccines |
None |
| 2010-10-08 |
Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study |
None |
| 2010-10-08 |
Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine |
None |
| 2010-10-08 |
NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants |
None |
| 2010-10-08 |
FDA files complaint for permanent injunction against Brooklyn Juice Company |
None |
| 2010-10-08 |
USPTO issues Patent Notice of Allowance for CIP-TRAMADOL ER drug |
None |
| 2010-10-08 |
CQ Healthbeat examines HIV prevention research funding |
None |
| 2010-10-07 |
Onyx Pharmaceuticals announces delay in NDA filing for carfilzomib |
None |
| 2010-10-07 |
Vical to manufacture pDNA vaccines against HIV |
None |
| 2010-10-07 |
Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing |
None |
| 2010-10-07 |
Sucampo submits marketing application for Amitiza drug |
None |
| 2010-10-07 |
Semi-synthetic opioid may improve withdrawal symptoms in infants |
None |
| 2010-10-07 |
Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines |
None |
| 2010-10-07 |
Cortex secures patent rights for combined use of AMPAKINE and mGluR5 compounds for Fragile X syndrome treatment |
None |
| 2010-10-07 |
ANDA approved for Losartan Potassium Tablets USP, Losartan Potassium and Hydrochlorothiazide Tablets |
None |
| 2010-10-07 |
Quintiles, SNUH announce clinical research partnership |
None |
| 2010-10-07 |
Roche receives development and commercialization rights for danoprevir drug |
None |
| 2010-10-07 |
New report focuses on management of renal anemia amongst dialysis, later stage CKD patients |
None |
| 2010-10-07 |
Pharmaxis receives FDA approval to market ARIDOL Test Kit |
5 |
| 2010-10-07 |
Gymnemic acid nanocrystals could help develop soluble drug compounds |
None |
| 2010-10-07 |
Raloxifene drug may be useful in treating kidney disease in women: Study |
None |
| 2010-10-07 |
FDA awards cooperative agreement to PAHO to develop information hub for medical products |
None |
| 2010-10-07 |
BioNJ creates special diagnostics committee to focus on personalized medicine |
None |
| 2010-10-07 |
FDA unveils report to advance regulatory science |
None |
| 2010-10-06 |
Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug |
None |
| 2010-10-06 |
CoreLab Partners completes first ever regulatory mandated Thorough QT study in the Asia Pacific Rim |
None |
| 2010-10-06 |
Ibuprofen provides pain relief within two hours in 49% of migraine sufferers |
None |
| 2010-10-06 |
Research to focus on effective use of artemisinin stocks for malaria |
None |
| 2010-10-06 |
Miller-Mccune examines impact of limited access to schistosomiasis drug in Africa |
None |
| 2010-10-06 |
Xeomin botulinum toxin for cervical dystonia now available in the U.S. |
None |
| 2010-10-06 |
Study on resistance of harmful bacteria to antibiotics |
None |
| 2010-10-06 |
New Wipro Rapid Trials platform launched to accelerate drug development |
None |
| 2010-10-06 |
Anticancer drug Cisplatin induces side effects |
5 |
| 2010-10-06 |
Watson seeks FDA approval to market rasagiline mesylate tablets |
None |
| 2010-10-06 |
CDC grant to support community-based public health project in RI and CT |
None |
| 2010-10-06 |
Health IT may bring unintended consequences |
None |
| 2010-10-06 |
Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1 |
None |
| 2010-10-06 |
Isogenica, NovaBiotics to accelerate the development of peptide anti-infective technology |
None |
| 2010-10-05 |
Tris Pharma receives FDA final approval for generic Tussionex ANDA |
None |
| 2010-10-05 |
FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency |
None |
| 2010-10-05 |
FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA |
None |
| 2010-10-05 |
FMCNA offers annual flu vaccine to patients and clinical staff |
None |
| 2010-10-05 |
Researchers complete first studies of mephedrone drug ban in Northern Ireland |
None |
| 2010-10-05 |
Octapharma USA launches wilate replacement therapy Web site for von Willebrand Disease |
None |
| 2010-10-05 |
Tasly, ProteoTech to co-develop Exebryl-1(R) medication for Alzheimer's disease treatment |
None |
| 2010-10-05 |
Researchers call for sustained funding to move HIV vaccine R&D ahead |
None |
| 2010-10-05 |
Novo Nordisk announces $73M expansion of Clayton insulin delivery systems manufacturing facility |
None |
| 2010-10-05 |
HGS receives Complete Response Letter from FDA for ZALBIN drug |
None |
| 2010-10-05 |
Merck to appeal against jury verdict in retrial of federal FOSAMAX case |
None |
| 2010-10-05 |
CPS recommends all Canadian babies should be vaccinated against rotavirus |
None |
| 2010-10-05 |
FDA approves Food Contact Notification for CDG Solution 3000 |
None |
| 2010-10-05 |
Aeras Global receives FDA grant to develop biomarkers for TB vaccine |
None |
| 2010-10-05 |
FDA awards $2.9 million to support tuberculosis research projects |
None |
| 2010-10-04 |
Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment |
None |
| 2010-10-04 |
NY Times: DEA crackdown means delays for some patients in need of pain meds |
None |
| 2010-10-04 |
Decision Resources: NSCLC drug market to grow from $4 billion in 2009 to over $6.5 billion in 2019 |
None |
| 2010-10-04 |
VIVUS announces divestiture of MUSE to Meda |
None |
| 2010-10-04 |
FDA clears Orthovita's VITOMATRIX Bone Graft Substitute for dental procedures |
None |
| 2010-10-04 |
J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA |
None |
| 2010-10-04 |
FDA provides Celsion guidance for Thermodox NDA to treat primary liver cancer |
None |
| 2010-10-04 |
Mylan subsidiary receives FDA approval for Fludarabine Phosphate Injection ANDA |
None |
| 2010-10-04 |
Merck to appeal Massachusetts federal court jury verdict |
None |
| 2010-10-04 |
NIH announces it will share IP rights to some AIDS drugs in UNITAID Patent Pool |
None |
| 2010-10-04 |
Study shows no difference between Bevacizumab and Ranibizumab efficacy in treating AMD |
None |
| 2010-10-04 |
New American Therapeutics acquires U.S. rights to market Denavir drug |
None |
| 2010-10-04 |
Report says drugmakers failing to give Medicaid adequate price data |
None |
| 2010-10-04 |
WHO says polio outbreak in Angola must be stopped to avoid 'international consequences' |
None |
| 2010-10-03 |
Icagen updates status of ICA-105665 clinical development program |
5 |
| 2010-10-03 |
Sulindac drug derivative effective in preventing colon cancer: Research |
None |
| 2010-10-01 |
Merck to pay millions over Mass. allegations of inflated wholesale rate |
None |
| 2010-10-01 |
Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility |
None |
| 2010-10-01 |
Noven acquires global rights to Daytrana from Shire affiliates |
None |
| 2010-10-01 |
USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA |
None |
| 2010-10-01 |
Cortex regains global rights to AMPAKINE compounds for treatment of schizophrenia and depression |
None |
| 2010-10-01 |
Mylan subsidiary launches Bupropion Hydrochloride Extended-release Tablets |
None |
| 2010-10-01 |
FDA issues Complete Response Letter for Teva's Neutroval BLA |
None |
| 2010-10-01 |
First nationwide Safe Medication Disposal Program launched |
None |
| 2010-10-01 |
FDA takes action against unapproved single-ingredient oral colchicine |
None |
| 2010-10-01 |
HIV/AIDS researchers, government officials track progress, forecast challenges for HIV vaccine development |
None |
| 2010-10-01 |
Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency |
None |
| 2010-10-01 |
APhA urges consumers to discuss proper medication usage with pharmacists |
None |
| 2010-10-01 |
Biologics can achieve great success - but at great cost |
None |